Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood plasma injection aims to wake up dormant ovaries in menopause

NCT ID NCT03916978

Recruiting now Disease control Sponsor: Genesis Athens Clinic Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether injecting a woman's own platelet-rich plasma (PRP) or platelet-free plasma (PFP) into her ovaries can restart menstrual cycles and improve hormone levels. The trial includes 100 women aged 45-55 who have been in menopause for at least a year. Researchers will measure if periods return and track changes in key fertility hormones over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Platelet-rich plasma (PRP) or platelet-free plasma (PFP) injected into the ovary
What this could lead to
If it works, this could offer a way to temporarily restore ovarian function and fertility in some menopausal women.
What could go wrong
This is an early-to-mid-stage trial with only 100 participants. The effect may be temporary or not work at all, and risks include infection or ovarian damage from the injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMENORRHEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amenorrhea anovulation female infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMENORRHEA ANOVULATORY INFERTILITY INFERTILITY, FEMALE MENOPAUSE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Genesis AC

    RECRUITING

    Athens, 15232, Greece

    Contact Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.